Login / Signup

Bone marrow stromal cell-mediated degradation of CD20 leads to primary rituximab resistance in mantle cell lymphoma.

Yoshiaki KurodaAkiko Yashima-AboDaisuke KoyamaJiro KikuchiShigehisa MoriShigeki ItoYusuke Furukawa
Published in: Leukemia (2020)
Keyphrases
  • bone marrow
  • mesenchymal stem cells
  • single cell
  • diffuse large b cell lymphoma
  • cell therapy
  • chronic lymphocytic leukemia
  • stem cells
  • nk cells